Advisor Group, Inc. - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 96 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q4 2017. The put-call ratio across all filers is 1.92 and the average weighting 0.5%.

Quarter-by-quarter ownership
Advisor Group, Inc. ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q4 2019$5,000
-58.3%
1,3750.0%0.00%
Q3 2019$12,000
-29.4%
1,375
-26.7%
0.00%
Q2 2019$17,000
-10.5%
1,875
-37.5%
0.00%
Q1 2019$19,000
+1800.0%
3,000
+8471.4%
0.00%
Q2 2018$1,0000.0%350.0%0.00%
Q1 2018$1,0000.0%350.0%0.00%
Q4 2017$1,0000.0%350.0%0.00%
Q3 2017$1,000350.00%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q4 2017
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 3,440,419$110,713,00017.54%
Consonance Capital Management LP 2,079,311$66,912,0006.04%
RTW INVESTMENTS, LP 1,063,170$34,213,0005.71%
Broadfin Capital, LLC 1,029,866$33,141,0005.42%
Perceptive Advisors 3,388,611$109,046,0003.62%
SECTORAL ASSET MANAGEMENT INC 854,301$27,491,0003.44%
Boxer Capital, LLC 267,500$8,608,0001.57%
Ghost Tree Capital, LLC 200,000$6,436,0001.51%
EMORY UNIVERSITY 51,632$1,662,0001.43%
Stanley-Laman Group, Ltd. 168,653$5,427,0001.17%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders